palmitic acid has been researched along with chymostatin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feng, P; Jin, L; Kong, Y; Li, C; Li, S; Lin, Y; Qiu, M; Wang, W; Xu, Y; Zhao, X | 1 |
1 other study(ies) available for palmitic acid and chymostatin
Article | Year |
---|---|
Combination of Chymostatin and Aliskiren attenuates ER stress induced by lipid overload in kidney tubular cells.
Topics: Activating Transcription Factor 4; Amides; Antihypertensive Agents; bcl-2-Associated X Protein; Caspase 3; Cell Line, Transformed; Cholesterol; Drug Combinations; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Endoribonucleases; Epithelial Cells; Eukaryotic Initiation Factor-2; Fumarates; Gene Expression Regulation; Heat-Shock Proteins; Humans; Kidney Tubules, Proximal; Oligopeptides; Palmitic Acid; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Receptor, Angiotensin, Type 1; Serine Proteinase Inhibitors; Signal Transduction; Transcription Factor CHOP | 2018 |